Can Employee Releases Bar False Claims Act Actions?
Client Alert | 1 min read | 03.15.06
Government contractors should take notice that recent court decisions indicate a possible shift in the law that may foretell greater success in using releases to bar False Claims Act qui tam actions by former employees. In their article “Employee Releases: A Tool Federal Contractors Can Use To Protect Themselves Against False Claims Act Liability” published in the February 21, 2006, BNA Federal Contracts Report (http://www.crowell.com/pdf/newsroom/FCR_Kunz-Goodman.pdf), Cathy Kunz and Jody Goodman of C&M discuss the jurisprudence that releases cannot be used to prevent former employees from bringing FCA actions against employers and analyze two recent decisions that diverge from this precedent and open the door for the enforcement of employee releases to bar qui tam actions.
Insights
Client Alert | 8 min read | 04.17.26
CMS Finalizes CY 2027 Medicare Advantage and Part D Rule: Key Implications for Plan Sponsors
On April 6, 2026, the Centers for Medicare & Medicaid Services (CMS) published its final rule governing the Medicare Advantage (Part C) and Prescription Drug Benefit (Part D) programs for Contract Year (CY) 2027. The final rule is effective June 1, 2026, with most provisions applicable to coverage beginning January 1, 2027, and marketing and communications changes taking effect October 1, 2026. Beyond payment, the rule pursues a broad deregulatory agenda aligned with Executive Order 14192, reversing marketing and enrollment safeguards introduced in 2023 and easing documentation and reporting obligations, while introducing new program integrity requirements.
Client Alert | 1 min read | 04.17.26
Client Alert | 3 min read | 04.17.26
Client Alert | 2 min read | 04.16.26
